Reuters logo
BRIEF-Delmar Pharmaceuticals collaborates with Duke University to explore VAL-083
April 25, 2017 / 12:41 PM / in 8 months

BRIEF-Delmar Pharmaceuticals collaborates with Duke University to explore VAL-083

April 25 (Reuters) - Delmar Pharmaceuticals Inc

* Delmar Pharmaceuticals collaborates with Duke University to explore VAL-083 as a front-line treatment for glioblastoma multiforme

* Delmar pharmaceuticals says it will fund a series of pre-clinical studies to be conducted by Duke University’s glioblastoma drug discovery group to evaluate VAL-083 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below